AEON Biopharma's total assets for Q2 2025 were $11.66M, a decrease of -15.49% from the previous quarter. AEON total liabilities were $27.51M for the fiscal quarter, a 9.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.